Get started
ZHENDE MEDICAL CO LTDZZ

ZHENDE MEDICAL CO LTD

21.54CNYD
−0.17−0.78%
At close at Mar 21, 09:16 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

603301 fundamentals

Key facts

Market capitalization‪5.69 B‬CNY
Dividend yield (indicated)5.80%
Price to earnings Ratio (TTM)28.01
Basic EPS (TTM)0.78CNY
Founded1994
Employees (FY)‪6.72 K‬
CEOJian Guo Lu
Websitezhende.com
About

Zhende Medical Co., Ltd. engages in the production, research, development, and sale of medical dressing. Its product categories include basic medical dressings, operating room sensory control, pressure therapy and fixation, stoma and chronic wounds, home care, and personal protection. The company was founded on August 18, 1994 and is headquartered in Shaoxing, China.

Ownership
‪‪265.10 M‬‬
Free Float shares
‪‪259.85 M‬‬ (98.02%)
Closely held shares
‪‪5.25 M‬‬ (1.98%)
Free Float shares
‪‪259.85 M‬‬ (98.02%)
Closely held shares
‪‪5.25 M‬‬ (1.98%)
Capital structure
Market cap
‪‪5.69 B‬‬
Debt
‪‪1.00 B‬‬
Minority interest
‪‪255.35 M‬‬
Cash & equivalents
‪‪1.11 B‬‬
Enterprise value
‪‪5.84 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪5.69 B‬‬
Price to earning ratio (P/E)
28.01x
Price to sales ratio (P/S)
1.44x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
28.01x
Price to sales ratio (P/S)
1.44x
Valuation ratios
‪0.00‬
‪0.45‬
‪0.90‬
‪1.35‬
‪1.80‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪12.00‬
‪24.00‬
‪36.00‬
‪48.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−14%‬
‪−7%‬
‪0%‬
‪7%‬
‪14%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−400.00 M‬‬
‪0.00‬
‪‪400.00 M‬‬
‪‪800.00 M‬‬
‪‪1.20 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
‪‪1.20 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
‪‪1.20 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Sensory Infection Control
Basic Care
Infection Control Protection
Ostomy and Modern Wound Care
Compression Therapy and Immobilization
Other
By country
Period: 2023
Overseas
China

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
‪‪1.20 B‬‬
Actual
Earnings
Next:Apr 26, 2025
2020
2021
2022
2023
2024
‪0.00‬
‪4.00‬
‪8.00‬
‪12.00‬
‪16.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
161.25%
Payout ratio (TTM)
Dividend yield TTM
5.76%
Last payment
0.50
Last ex-date
Jul 3, 2024
Dividend history
‪1.0%‬
‪2.1%‬
‪3.2%‬
‪4.3%‬
‪5.4%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−600.00 M‬‬
‪0.00‬
‪‪600.00 M‬‬
‪‪1.20 B‬‬
‪‪1.80 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪1.20 B‬‬
‪‪2.40 B‬‬
‪‪3.60 B‬‬
‪‪4.80 B‬‬
Assets
Liabilities